NVT vs. AXSM
NVT (nVent Electric plc) and AXSM (Axsome Therapeutics, Inc.) are both stocks. NVT operates in Electrical Equipment & Parts (Industrials), while AXSM operates in Biotechnology (Healthcare). Over the past 5 years, NVT returned 39.10%/yr vs 35.01%/yr for AXSM. Their 0.19 correlation means their historical movements had little consistent relationship.
Performance
NVT vs. AXSM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVT achieves a 51.57% return, which is significantly higher than AXSM's 19.36% return.
NVT
- 1D
- 6.24%
- 1M
- -3.72%
- 6M
- 37.41%
- YTD
- 51.57%
- 1Y
- 97.47%
- 3Y*
- 42.62%
- 5Y*
- 39.10%
- 10Y*
- —
- ALL TIME*
- 29.74%
AXSM
- 1D
- -7.10%
- 1M
- -9.42%
- 6M
- 18.31%
- YTD
- 19.36%
- 1Y
- 115.02%
- 3Y*
- 41.26%
- 5Y*
- 35.01%
- 10Y*
- 39.83%
- ALL TIME*
- 34.71%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $153.10M | $171.36M | $209.26M | |
| $373.02M | $340.45M | $350.68M |
NVT vs. AXSM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
NVT nVent Electric plc | 51.57% | 51.27% | 16.63% | 55.98% | 3.32% | 67.15% | -5.68% | 17.24% | 7.52% |
AXSM Axsome Therapeutics, Inc. | 19.36% | 115.86% | 6.31% | 3.19% | 104.16% | -53.63% | -21.18% | 3,565.25% | -17.06% |
Correlation
The correlation between NVT and AXSM is 0.21, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.21 |
Correlation (3Y) Balances recent behavior with more history. | 0.17 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.19 |
Correlation (All Time) Calculated using the full available price history since May 1, 2018 | 0.19 |
Fundamentals
NVT:
$24.88B
AXSM:
$11.22B
NVT:
$3.63
AXSM:
-$3.72
NVT:
5.23
AXSM:
15.58
NVT:
6.33
AXSM:
204.46
NVT:
$4.83B
AXSM:
$708.24M
NVT:
$1.79B
AXSM:
$655.82M
NVT:
$1.01B
AXSM:
-$172.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVT vs. AXSM — Risk / Return Rank
NVT
AXSM
NVT vs. AXSM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for nVent Electric plc (NVT) and Axsome Therapeutics, Inc. (AXSM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVT | AXSM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.56 | ||
| Sortino ratioReturn per unit of downside risk | -1.26 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 1.47 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | 3.57 | 6.25 | -2.68 |
| Martin ratioReturn relative to average drawdown | 13.66 | 18.02 | -4.36 |
Loading charts...
Drawdowns
NVT vs. AXSM - Drawdown Comparison
The maximum NVT drawdown since its inception was -56.18%, smaller than the maximum AXSM drawdown of -86.65%. Use the drawdown chart below to compare losses from any high point for NVT and AXSM.
Loading charts...
Drawdown Indicators
| NVT | AXSM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -56.18% | -86.65% | +30.47% |
Max Drawdown (1Y)Largest decline over 1 year | -27.42% | -18.50% | -8.92% |
Max Drawdown (3Y)Largest decline over 3 years | -46.67% | -32.69% | -13.98% |
Max Drawdown (5Y)Largest decline over 5 years | -46.67% | -61.08% | +14.41% |
Max Drawdown (10Y)Largest decline over 10 years | — | -81.26% | — |
Current DrawdownCurrent decline from peak | -16.44% | -14.57% | -1.87% |
Average DrawdownAverage peak-to-trough decline | -11.83% | -39.06% | +27.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.16% | 6.41% | +0.75% |
Volatility
NVT vs. AXSM - Volatility Comparison
nVent Electric plc (NVT) has a higher volatility of 16.96% compared to Axsome Therapeutics, Inc. (AXSM) at 14.94%. This indicates that NVT's price experiences larger fluctuations and is considered to be riskier than AXSM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVT | AXSM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.96% | 14.94% | +2.02% |
Volatility (6M)Calculated over the trailing 6-month period | 36.03% | 28.72% | +7.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 45.95% | 42.96% | +2.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.09% | 70.11% | -33.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.93% | 90.38% | -51.45% |
Dividends
NVT vs. AXSM - Dividend Comparison
NVT's dividend yield for the trailing twelve months is around 0.54%, while AXSM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
AXSM Axsome Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVT nVent Electric plc | 0.54% | 0.78% | 1.12% | 1.18% | 1.82% | 1.84% | 3.01% | 2.74% | 1.56% |
Financials
NVT vs. AXSM - Financials Comparison
This section allows you to compare key financial metrics between nVent Electric plc and Axsome Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NVT vs. AXSM - Profitability Comparison
NVT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, nVent Electric plc reported a gross profit of 558.00M and revenue of 1.47B. Therefore, the gross margin over that period was 37.9%.
AXSM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported a gross profit of 176.48M and revenue of 191.20M. Therefore, the gross margin over that period was 92.3%.
NVT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, nVent Electric plc reported an operating income of 300.70M and revenue of 1.47B, resulting in an operating margin of 20.4%.
AXSM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported an operating income of -63.36M and revenue of 191.20M, resulting in an operating margin of -33.1%.
NVT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, nVent Electric plc reported a net income of 215.90M and revenue of 1.47B, resulting in a net margin of 14.7%.
AXSM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Axsome Therapeutics, Inc. reported a net income of -64.54M and revenue of 191.20M, resulting in a net margin of -33.8%.
Frequently Asked Questions
NVT and AXSM have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVT has higher volatility (16.96%) compared to AXSM (14.94%). In terms of maximum drawdown, NVT dropped -56.18% vs AXSM's -86.65%.
AXSM currently has the higher Sharpe Ratio (2.69 vs 2.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVT and AXSM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer